I now have excellent, detailed information from multiple authoritative textbooks. Let me compile a comprehensive answer.
Management of Diabetic Ketoacidosis (DKA)
DKA is a medical emergency defined by the triad of hyperglycemia (glucose >250 mg/dL), ketonemia/ketonuria (2+ or >3.0 mmol/L), and metabolic acidosis (pH <7.3, bicarbonate <18 mmol/L).
Severity Classification
| Severity | pH | HCO₃ | Mental Status |
|---|
| Mild | 7.25–7.30 | 15–18 | Alert |
| Moderate | 7.00–7.24 | 10–14 | Drowsy |
| Severe | <7.00 | <10 | Stupor/Coma |
The 5 Pillars of DKA Management
1. Fluid Resuscitation
Fluid losses are typically 5–10 liters in adults (water deficit ~70-100 mL/kg).
- If in hypovolemic shock: Give isotonic crystalloid (0.9% NS) as fast as possible in adults; 20 mL/kg bolus in children, repeated until systolic BP ≥80 mmHg
- Moderate dehydration (no shock): 1–2 L of 0.9% NS over the first 1–2 hours, then 15–20 mL/kg/h
- After initial resuscitation: Switch to 0.45% NS (hypotonic saline) at a slower rate
- When glucose falls to ≤250–300 mg/dL: Add dextrose 5% (D5W) to IV fluids (while continuing insulin) to prevent hypoglycemia and allow ongoing insulin to clear ketones
Note: Large volumes of 0.9% NS can worsen hyperchloremic metabolic acidosis. Balanced crystalloids (Plasmalyte) show promise for faster normalization of physiologic parameters. - Rosen's Emergency Medicine, p. 2544
2. Insulin Therapy
Critical rule: Do NOT start insulin if K⁺ < 3.3 mEq/L - correct potassium first.
- Mild–Moderate DKA: Can be treated with subcutaneous rapid-acting insulin analogs (recent evidence supports this as an alternative to IV infusion)
- Severe DKA: Requires IV regular insulin
Standard IV Protocol:
- Option A: 0.1 unit/kg/h continuous infusion (no bolus)
- Option B: 0.1 unit/kg IV bolus, then 0.1 unit/kg/h infusion
- If glucose does not fall by ≥10% in the first hour: give a rescue bolus of 0.1 unit/kg
Glucose targets during treatment:
- Target glucose fall: 50–70 mg/dL/hr
- When glucose reaches 250 mg/dL: Add D5W to fluids, reduce insulin to 0.05–0.1 unit/kg/h to maintain glucose 150–250 mg/dL
- Continue insulin until ketoacidosis resolves (pH >7.3, HCO₃ >15, anion gap normalized)
Transition to subcutaneous insulin:
- Give first dose of SC insulin 1–2 hours before stopping IV infusion to prevent rebound ketosis
Barash's Clinical Anesthesia, p. 4059; Rosen's Emergency Medicine, p. 2544
3. Potassium Replacement
Despite often-normal or high initial serum K⁺ (due to acidosis pushing K⁺ extracellularly), total body potassium is always depleted (deficit 3–7 mEq/kg). Once insulin starts and acidosis corrects, K⁺ shifts intracellularly and levels can plummet dangerously.
| Serum K⁺ | Action |
|---|
| < 3.3 mEq/L | Hold insulin; give IV K⁺ first; replace to >3.3 mEq/L before starting insulin |
| 3.3–5.5 mEq/L | Give insulin + add 20–40 mEq KCl per liter of IV fluid; maintain K⁺ 4–5 mEq/L |
| > 5.5 mEq/L | Give insulin; hold K⁺; monitor every 2 hours |
Continuous ECG monitoring is recommended when K⁺ replacement rate exceeds 10 mEq/h. - Barash's Clinical Anesthesia, p. 4059
4. Other Electrolytes
Phosphate:
- Levels fall during treatment (insulin drives phosphate intracellularly)
- Routine replacement is generally not necessary unless severe hypophosphatemia develops (can cause skeletal muscle weakness, impaired ventilation, hemolytic anemia)
- Replace if serum phosphate < 1.0 mg/dL
Magnesium:
- Correct with 1–2 g MgSO₄ IV if deficient; serum levels may not reflect body stores
Sodium:
- Corrected with 0.9% NS or 0.45% NS depending on phase of resuscitation
- Measured Na⁺ is often falsely low due to osmotic shift from hyperglycemia (correct: add 1.6–2.4 mEq/L Na⁺ per 100 mg/dL glucose above 100 mg/dL)
5. Bicarbonate Therapy
Generally NOT recommended - multiple studies show no benefit in resolution of acidosis or time to discharge.
Only consider if:
- pH < 7.1 with hemodynamic instability, OR
- pH < 6.9 even without hemodynamic instability
Give 50–100 mEq NaHCO₃ IV if indicated, with close monitoring.
Identify and Treat the Precipitant
Always search for the underlying cause (the most common precipitants are listed in Goldman-Cecil Medicine):
- Most common: Infections, insulin non-adherence, new-onset T1DM, acute coronary syndrome
- Others: Stroke, pulmonary embolism, pancreatitis, medications (corticosteroids, SGLT2 inhibitors, atypical antipsychotics, cocaine)
Special Situations
SGLT2 Inhibitor-Associated (Euglycemic) DKA
- Blood glucose may be normal or only mildly elevated - can be missed
- SGLT2 inhibitor effect persists 10–14 days after discontinuation
- Treat the same way; maintain dextrose in IV fluids; avoid stopping insulin prematurely
Airway/Intubation
- Avoid intubation if possible - the patient's tremendous respiratory drive (Kussmaul breathing) is compensatory; matching it on a ventilator is challenging
- If intubation is necessary (comatose, vomiting), maintain hyperventilation post-intubation to prevent acidosis worsening
Monitoring (Meticulous Flow Sheet)
| Parameter | Frequency |
|---|
| Glucose | Every 1 hour |
| K⁺, Na⁺, Cl⁻, HCO₃⁻, pH | Every 2–4 hours |
| Fluid in/urine out | Hourly |
| Vital signs | Continuous |
| ECG | Continuous (if high-dose K⁺ replacement) |
Resolution Criteria (DKA "Cleared")
- Blood glucose < 200 mg/dL
- Serum bicarbonate ≥ 15 mEq/L
- Venous pH > 7.3
- Anion gap normalized (≤12 mEq/L)
Recent Evidence Update
Recent meta-analyses (2024–2026) are refining protocols:
- A 2024 meta-analysis (PMID 39090718) found subcutaneous insulin to be a safe and effective alternative to continuous IV infusion in adult DKA - shorter hospital stays with comparable outcomes
- A 2026 meta-analysis (PMID 41208563) on early subcutaneous basal insulin co-administered with IV insulin found it reduced time to transition and shortened hospital stay without increasing hypoglycemia
Sources: Rosen's Emergency Medicine, p. 2542-2545; Goldman-Cecil Medicine, p. 2484; Barash's Clinical Anesthesia, p. 4059; ADA Potassium/Phosphorus Repletion Guidelines